Case report: Diagnosis of hereditary hemorrhagic telangiectasia (Osler Weber Rendu Syndrome) in a 23-year-old male presented with anemia and thrombocytopenia and its response to bevacizumab

Case report: Diagnosis of hereditary hemorrhagic telangiectasia (Osler Weber Rendu Syndrome) in a 23-year-old male presented with anemia and thrombocytopenia and its response to bevacizumab

Osler Weber Rendu Syndrome (OWS) is characterized by the development of abnormally dilated blood vessels, which manifest as arteriovenous shunts (pulmonary, gastrointestinal, hepatic, and cerebral) and mucocutaneous telangiectasias (lips, tongue, and fingertips). It is an autosomal dominant disease...

Full description

Bibliographic Details
Main Authors: Hamza Yunus, Said Amin, Furqan Ul Haq, Waqar Ali, Tanveer Hamid, Wajid Ali, Basharat Ullah, Payal Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
hereditary hemorrhagic telangiectasia
Osler Weber Rendu Syndrome
diagnosis
management
bevacizumab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1001695/full

Similar Items

Similar Items